Phase 2 study of SYM004 for adult patients with recurrent glioblastoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Symphogen A/S
Start Date
November 1, 2015
End Date
October 31, 2021
Administered By
Duke Cancer Institute
Awarded By
Symphogen A/S
Start Date
November 1, 2015
End Date
October 31, 2021